Bies J R, Ellis J H, Kopecky K K, Sutton G P, Klatte E C, Stehman F B, Ehrlich C E
AJR Am J Roentgenol. 1984 Dec;143(6):1249-57. doi: 10.2214/ajr.143.6.1249.
Thirty-eight patients with gynecologic malignancies (ovarian, cervical, and endometrial carcinoma) underwent computed tomography (CT) and magnetic resonance imaging (MRI) of the abdomen and pelvis. Results of these studies were compared with each other as well as with clinical staging and surgical findings when possible. CT and MRI correctly staged 64% (nine of 14) of patients with cervical carcinoma. In patients suspected of residual or recurrent disease, CT and MRI were each correct in 75% (15 of 20), four of the errors being due to inability to distinguish inflammation or radiation changes from recurrent tumor. CT and 0.15-T resistive MRI are of equal value in screening for residual or recurrent disease and as an adjunct to clinical staging; further advances in MRI technology may alter this impression.
38例妇科恶性肿瘤（卵巢癌、宫颈癌和子宫内膜癌）患者接受了腹部和盆腔的计算机断层扫描（CT）及磁共振成像（MRI）检查。这些检查结果相互之间以及在可能的情况下与临床分期和手术结果进行了比较。CT和MRI对64%（14例中的9例）的宫颈癌患者分期正确。在怀疑有残留或复发性疾病的患者中，CT和MRI的诊断正确率均为75%（20例中的15例），其中4例错误是由于无法区分炎症或放疗改变与复发性肿瘤。CT和0.15-T电阻性MRI在筛查残留或复发性疾病以及作为临床分期的辅助手段方面具有同等价值；MRI技术的进一步发展可能会改变这一印象。
